MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

Technology use and impulse control disorders (ICDs) in patients with Parkinson’s disease (PD)

E.A. Byrd, C.M. Tanner, C.A. Racine, N.B. Galifianakis (San Francisco, CA, USA)

Meeting: 2016 International Congress

Abstract Number: 1485

Keywords: Behavioral abnormalities, Dopamine agonists, Parkinsonism

Session Information

Date: Wednesday, June 22, 2016

Session Title: Parkinson's disease: Psychiatric manifestations

Session Time: 12:00pm-1:30pm

Location: Exhibit Hall located in Hall B, Level 2

Objective: To ascertain the prevalence of problematic technology use (Technology-related ICDs, Tech-ICDs) in patients with PD.

Background: ICDs are a known complication of PD drugs causing serious harm, but problematic use of technology is not a recognized ICD. We have noticed multiple patients in our clinic with Tech-ICDs that were not detected using standard screens. To address this, we are systematically collecting detailed information on technology use in PD and matched controls. We hypothesize that Tech-ICDs are common in PD.

Methods: Consecutive PD cases and controls from our movement disorders center are being evaluated. Controls are cases’ caregivers or family members. Subjects are evaluated once by clinical status, MoCA, QUIP and a structured screen for Tech-ICDs, the PUTS-PD (Problematic Use of Technology Scale-PD) elaborated by a semi-structured interview (SSI). Technology use was defined as problematic when it was excessive or disruptive enough to cause impairment or harm to an individual based on SSI.

Results: To date, 16 PD cases (mean PD duration 10 years, mean levodopa-equivalent daily dose 946 mg, 44% on dopamine agonist) and 8 controls have completed the PUTS-PD. Mean MoCA was 27/30 in PD and 28/30 in controls. QUIP was positive in 67% of PD and 33 % of controls. Most subjects owned multiple devices (smartphone: 81% PD, 88% controls; tablet: 44% PD, 63% controls; laptop/desktop: 94% PD, 100% controls). 7 of 16 PD cases (44%) but only 1 control (13%) reported problematic use of technology now or in the past (among PD, 57% past, 29% now, 14% both; among control, both) on PUTS-PD. 9 PD completed the SSI; 44% were found to have Tech-ICD. All of PD with Tech-ICD also had classic ICD behaviors. Only 2 controls completed SSI and neither was found to have Tech-ICD or classic ICD behaviors. 55% of PD with Tech-ICD endorsed “escaping” or feeling in a “zone” with technology use. 100% with these feelings but only 25% without these feelings had a history of depression or anxiety.

Conclusions: Our preliminary result suggests that problematic technology use is common in PD and appears to occur more often in those with other ICDs. Additional screening methods are needed to identify these potentially harmful behaviors.

To cite this abstract in AMA style:

E.A. Byrd, C.M. Tanner, C.A. Racine, N.B. Galifianakis. Technology use and impulse control disorders (ICDs) in patients with Parkinson’s disease (PD) [abstract]. Mov Disord. 2016; 31 (suppl 2). https://www.mdsabstracts.org/abstract/technology-use-and-impulse-control-disorders-icds-in-patients-with-parkinsons-disease-pd/. Accessed May 15, 2025.
  • Tweet
  • Email
  • Print

« Back to 2016 International Congress

MDS Abstracts - https://www.mdsabstracts.org/abstract/technology-use-and-impulse-control-disorders-icds-in-patients-with-parkinsons-disease-pd/

Most Viewed Abstracts

  • This Week
  • This Month
  • All Time
  • Yerba Mate (Ilex paraguaiensis) protects dopaminergic neurons degeneration and improve their maturation in culture
  • #26133 (not found)
  • Effect of marijuana on Essential Tremor: A case report
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Estimation of the 2020 Global Population of Parkinson’s Disease (PD)
  • Patients with Essential Tremor Live Longer than their Relatives
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley